Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-11-05, the close was $49.64: 5.0% below the 50-day average and 3.1% below the 200-day average, which is rising. RSI (14) is 42, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 60% of the way up its 52-week range of $33.85 to $60.15, on 1.5x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $52.28 | Price 5.0% below |
| 200-day average | $51.21 | Price 3.1% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 42 | Neutral range |
| MACD (12, 26, 9) | +0.25 vs +0.27 | Bearish cross in the last 10 days |
| 52-week range | $33.85 to $60.15 | 60% of the way up the range |
| Volume vs 20-day average | 1.5x | Heavy |
Base rates use SLB's own daily history since 1999; they describe the past, not a forecast.
As of 2026-11-05, SLB's 14-day RSI is 42, which is in the neutral range between 30 and 70.
No. SLB closed at $49.64 on 2026-11-05, 3.1% below its 200-day average of $51.21, which is rising. When it closed below its 200-day average (2,914 days), it was higher 63 trading days later 52% of the time, median +0.9%.
No. SLB closed at $49.64 on 2026-11-05, 5.0% below its 50-day average of $52.28. When it closed below its 50-day average (3,111 days), it was higher 63 trading days later 56% of the time, median +2.7%.
Yes, a bearish cross within the last 10 trading days. As of 2026-11-05 the MACD line is +0.25 against a signal line of +0.27, so MACD is bearish.
No. At $49.64 it sits 60% of the way up its 52-week range of $33.85 to $60.15, 17.5% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: S-Buy, from the chart signal model.
SLB analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.